Peloton IPO

Discussion in 'Wall St. News' started by dealmaker, Sep 27, 2019.

  1. dealmaker

    dealmaker

    Peloton IPO


    Peloton's IPO, one of the season's most keenly watched, didn't go so great. With an IPO price of $29, the fitness firm's stock ended yesterday 11.2% lower at $25.76. That's the second-biggest IPO flop of the year, after SmileDirectClub. No matter, said CEO John Foley. "I will say a lot of these young tech companies get criticized for staying in the private markets too long, and I feel like if we would have waited any longer we might have been painted with the same brush, so it felt like this was the right time." Fortune
     
  2. dealmaker

    dealmaker

    Citron Research Presents Peloton – Investors Peddling Themselves into Frenzy

    2020 Price Target $5
    [​IMG]
    [​IMG]
    [​IMG]
    [​IMG]
    [​IMG] [​IMG]

    Before we even start with the narrative, we are obligated to show the only chart that matters.

    Unless Peloton invents a piece of equipment that works out for you – this is going to $5 (which is still a $1BN-$2BN market cap).
    Looking back over the past 5 years, one of biggest trading regrets held by Citron was not being more aggressive and staying short GoPro from the article we published in late 2014.

    https://citronresearch.com/wp-content/uploads/2014/11/gpro-final.pdf
    While Wall St was giddy over the new “must have product”, Citron maintained that GoPro sold a consumer electronics device that would eventually show decelerating growth as competition came into the marketplace. At the end of the day no matter how much lipstick Wall St put on this company, it was just a camera – the rest is history.
    Disclosure: Yes, we own a Peloton bike just like we owned a GoPro, Fitbit, Blackberry, and even an ab roller… but who cares.


    Read the Full Report Here
    Disclaimer:
    These reports have been prepared by either Citron Research (“Citron Research”) or Citron Capital, LLC (“Citron Capital”). Citron Research and Citron Capital are referred to collectively as “Citron” and each individually as a “Citron Entity.” Each report specifies the publisher and owner of that report. All reports are for informational purposes only. Under no circumstances should any of these reports or any information herein be construed as investment advice, or as an offer to sell or the solicitation of an offer to buy any securities or other financial instruments.
    Citron Research produces research reports on publicly traded securities. The reports are the property of the applicable Citron Entity that published that report. The opinions, information and reports set forth herein are solely attributable to the applicable Citron Entity and are not attributable to any Citron Related Person (defined below) (other than the Citron Entity that published the report).
    By downloading, accessing, or viewing any research report, you agree to the following Terms of Use. You agree that use of the research presented in any report is at your own risk. You (or any person you are acting as agent for) agree to hold harmless Citron Research, Citron Capital and each of their affiliates and related parties, including, but not limited to any principals, officers, directors, employees, members, clients, investors, consultants and agents (collectively, the “Citron Related Persons”) for any direct or indirect losses (including trading losses) attributable to any information in a research report. You further agree to do your own research and due diligence before making any investment decision with respect to securities of the issuers covered herein (each, a “Covered Issuer”) or any other financial instruments that reference the Covered Issuer or any securities issued by the Covered Issuer. You represent that you have sufficient investment sophistication to critically assess the information, analysis and opinion presented in any Citron report. You further agree that you will not communicate the contents of reports and other materials made available by Citron to any other person unless that person has agreed to be bound by these Terms of Use. If you access, download or receive the contents of Citron reports or other materials on your own behalf, you agree to and shall be bound by these Terms of Use. If you access, download or receive the contents of Citron reports or other materials as an agent for any other person, you are binding your principal to these same Terms of Use.
    You should assume that, as of the publication date of a Citron report, Citron Related Persons (possibly along with or through its members, partners, affiliates, employees, and/or consultants), Citron Related Persons clients and/or investors and/or their clients and/or investors have a position (long or short) in one or more of the securities of a Covered Issuer (and/or options, swaps, and other derivatives related to one or more of these securities), and therefore may realize significant gains in the event that the prices of a Covered Issuer’s securities decline or appreciate. Citron Research, Citron Capital and/or the Citron Related Persons may continue to transact in Covered Issuers’ securities for an indefinite period after an initial report on a Covered Issuer, and such position(s) may be long, short, or neutral at any time hereafter regardless of their initial position(s) and views as stated in the Citron research. Neither Citron Research nor Citron Capital will update any report or information to reflect changes in positions that may be held by a Citron Related Person.
    This is not an offer to sell or a solicitation of an offer to buy any security. Neither Citron Research nor any Citron Related Person (including Citron Capital) are offering, selling or buying any security to or from any person through any Citron research reports. Citron Research is affiliated with Citron Capital. Citron Capital does not render investment advice to anyone unless it has an investment adviser-client relationship with that person evidenced in writing. You understand and agree that Citron Capital does not have any investment advisory relationship with you or does not owe fiduciary duties to you. Giving investment advice requires knowledge of your financial situation, investment objectives, and risk tolerance, and Citron Capital has no such knowledge about you.
     
    apdxyk and nooby_mcnoob like this.
  3. dealmaker

    dealmaker

  4. Amun Ra

    Amun Ra


    Peloton is a Becky stock. Never bet against Becky.
     
  5. dealmaker

    dealmaker

    ""
     
  6. Cuddles

    Cuddles

    to this day, I don't even know what they do. Spinning classes?
     
  7. dealmaker

    dealmaker

  8. dealmaker

    dealmaker

    • Peloton’s Q4 earnings showed a 172% YoY jump in revenue, and its connected subscribers were up 113% YoY.
    The pandemic has exploded the market for digital fitness
    There are 62m gym memberships in the US and 183m globally, according to a 2019 report.

    But many people shifted to online workouts during the pandemic, and gyms have been slow to reopen.

    Many notable gym brands have filed for bankruptcy in recent months, according to PETITION: Gold’s Gym, 24-Hour Fitness, SNFW Fitness (Steve Nash’s), Town Sports International (New York Sports Club). They posit that high-end Equinox could be next.
     
  9. dealmaker

    dealmaker

  10. wrbtrader

    wrbtrader

    #10     Oct 12, 2020